期刊文献+

高龄患者利奈唑胺致血小板降低3例 被引量:1

原文传递
导出
摘要 患者1,男性,85岁,因下咽癌3年余,颈部包块增大4月,皮肤破溃3月。”于2008年11月20日入院,入院诊断:(1)下咽癌放疗后,右颈部淋巴结转移;(2)肺栓塞,呼吸衰竭;(3)慢性支气管炎,慢性阻塞性肺气肿;(4)冠心病,
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第20期1744-1745,共2页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献7

  • 1邓雪娥.利奈唑胺[J].中国新药杂志,2001,10(11):864-866. 被引量:9
  • 2Attassi K, Hershberger E, Alam R, et al. Thrombocytopenia associated with linezolid therapy[J]. Clin Infect Dis, 2002, 34 (5): 695 -698.
  • 3Garazzino S, De Rosa FG, Bargiacchi O, et al. Haematological safety o{ long term therapy with linezolid[J].Int J Antimierob Agents,2007, 29(4): 480 -483.
  • 4Lin YH, Wu VC, Tsai IJ, et al. High frequency of linezolid associated thrombocytopenia among patients with renal insufficiency[J]. Int J Antimicrob Agents,2006,28(4):345-351.
  • 5Attassi K, Hershberger E, Alam R, et al. Thromboeytopenia associated with linezolid therapy[J].Clin Infect Dis, 2002,34 (5) :695-698.
  • 6邹琳,刘长庭.利奈唑胺在高龄老年患者中的临床应用[J].中华医院感染学杂志,2010,20(3):399-401. 被引量:22
  • 7Bernstein WB, Trotta RF, Rector JT, et al. Mechanisms for linezolid induced anemia and thrombocytopenia[J].Ann Phar macother,2003,37(4) :517 -520.

二级参考文献9

  • 1裴斐,王睿.磷霉素与替考拉宁对90株革兰阳性球菌的联合药敏研究[J].中华医院感染学杂志,2004,14(11):1282-1284. 被引量:11
  • 2Hayden MK. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci[J]. Clin Infect Dis,2001,31(4) :1058-1065.
  • 3Kohno S, Yamaguchi K, Aikawa N. Linezolid versus vanco mycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan [J]. J Antimicrob Chemother, 2007,60(6) : 1361-1369.
  • 4Lin DF,Zhang YY,Wu JF. Linezolid for the treatment of infections caused by Gram-positive pathogens in China[J]. Int J Antimicrob Agents, 2008,32 (3): 241-249.
  • 5Wilcox M, Nathwani D. Dryden M. Linezolid compared with teicoplanin for the treatment of suspected or proven Grampositive infections[J]. J Antimicrob Chemother,2004,53(2) : 335-344.
  • 6[1]Diekema DJ, Jones RN. Oxazolidinones[J]. Drugs, 2000,59(1):7-16.
  • 7刘坤,李有信,杜晓玲.耐万古霉素肠球菌医院感染危险因素分析[J].中华医院感染学杂志,2007,17(8):1000-1002. 被引量:17
  • 8肖永红,王进,赵彩云,高磊,郑波,薛峰,李湘艳,郝凤兰,代表Mohnarin协作组.2006-2007年Mohnarin细菌耐药监测[J].中华医院感染学杂志,2008,18(8):1051-1056. 被引量:607
  • 9汪复.抗菌药物临床应用进展[J].中国抗感染化疗杂志,2002,2(2):115-119. 被引量:39

共引文献29

同被引文献19

  • 1周践,周筱青.65例亚胺培南/西司他丁药品不良反应分析[J].中华医院感染学杂志,2004,14(6):671-673. 被引量:19
  • 2冯祚臻,官东秀.亚胺培南/西司他丁不良反应57例文献分析[J].中国药业,2006,15(16):39-39. 被引量:13
  • 3McGhan RM.Clinical respiratory medicine(third edition):corticosteroids[M].Philadelphia, Mosby:Academic Press,2003:483 -489.
  • 4Marinho DS,Huf G,Ferreira BL,et al.The study of vancomycin use and its adverse reactions associated to patients of a Brazilian university hospital[J].BMC Res notes,2011,4(1):236.
  • 5Wood MJ. Comparative safety ofteicop lanin and vancomycin [J]. J Chemother,2000,12 (Supp 15):21-251.
  • 6Svetitsky S,Leibovici L,Paul M.Comparative efficacy and safety of vaneomycin versus teicoplanin:systematic review and meta- analysis[J]. Antimicrob Agents Chemother,2009, 53(10):4069.
  • 7Editorial.Red man should go:vancomycin and hisfamine release[J]. Lancet, 1990,335(8696): 1006.
  • 8Renz CL,Thurn JD,Finn HA,et all Antihistamine prophylaxis permmits rapid vancomycin infusion[J].Crit Care Med, 1999,27(9): 1732-1737.
  • 9Espersen F, farlov J O,Jensen C,et al.Staphylococcus aureus peptidoglycan induces histamine release from basophil human leukocytes in vitro [J].Infect Immun, 1984,46:710.
  • 10Renz CL,Thurn JD, Finn HA, Lynch JP, Moss J.Clinical investigations:antihistamine prophylaxis permits rapid vancomycin infusion[J].Crit Care Med, 1999, 27:1732.

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部